Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Manage alerts
Active alerts for CORONA Remedies
Add new alert
CORONA •
NSE
CORONA Remedies
₹1,740.60
8.90 (0.51%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
ScoutQuest •
12 hours ago
Corona Remedies' FY26 revenue reached ₹1,403.2 Cr, up 17.3% YoY; EBITDA rose 22.3%. Company's PAT surged 33.4% with a successful IPO in Dec '25, 101x subscribed.
BSE •
13 hours ago
Corona Remedies Ltd announces its 22nd AGM on July 9, 2026, via VC/OAVM and shares its FY25-26 Annual Report. Corona Remedies achieved 17.2% revenue growth in FY25-26, outpacing IPM growth of 8.6%, and strengthened chronic care focus.
ScoutQuest •
3 weeks ago
Corona Remedies got EU GMP certification for hormone manufacturing facility. Renewed EU GMP approval for Oral Solid Dosage facility in Bhayla after April 2026 inspection.
ScoutQuest •
4 weeks ago
Corona Remedies' FY26 revenue rose 17.3% YoY to INR 1,403 cr; PAT surged 33.4% to INR 199 cr. Two brands crossed INR 100 cr revenue; focus on chronic therapies and biosimilars expansion.
BSE •
1 month ago
Corona Remedies Ltd announces audited financial results for FY26, with net profit at Rs. 184.9 crore, up from Rs. 149.1 crore in FY25. The board approves a Rs. 10/share dividend, subject to AGM approval, and appoints auditors for upcoming years.
The Hindu BusinessLine •
1 month ago
Corona Remedies Q4 PAT surges 44%, driven by strong sales growth. The firm declares a ₹10/share final dividend for FY26.
Livesquawk •
1 month ago
Corona Remedies declares a final dividend of ₹10/share.
Livesquawk •
1 month ago
Corona Remedies Q4 EBITDA rose 13% YoY to ₹610M from ₹540M. EBITDA margin declined to 17.3% from 18.4%, down 1.1 percentage points YoY.
Moneycontrol •
1 month ago
CMS Info Systems, Oberoi Realty, Tata Consumer Products among stocks in focus today, May 11. Corona Remedies, UPL, Canara Bank, Indian Hotels to announce Q4 results for March 2026.
ScoutQuest •
2 months ago
Corona Remedies aims for 20-25% CAGR growth for Wokadine over 3 years.